KEOSF Stock DD Kelso Technologies, Inc. 08/28/2014 08:09:39

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
KEOSF Kelso Technologies, Inc. $KEOSF Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=KEOSF&am...mp;yt0=Go!

Last Updated: 08/28/2014 08:09:34

Current Price and Quotes
Last Price 6.00
Previous Close 5.91 Open 5.91
Daily Range N/A - 6.00 52wk Range 1.37 - 6.737
Volume 29,125 Dividend 0.01
Average Vol (30d) 14,757 Yield 0.166667




Financials
Period Ending Dec 31, 2013
Total Revenue 13,131
Cost of Revenue 7,826
Gross Profit 5,305
Operating Expenses

Research and Development 253
Sales, General and Admin. 3,123
Non-Recurring Items 168
Other 3
Operating Income 1,758
Income From Continuing Operations

Add'l Income/Expense Items (134)
Earnings Before Interest and Tax 1,624
Interest Expense -
Earnings Before Tax 1,624
Income Tax (832)
Minority Interest -
Equity Earnings Unconsolidated Subsidiary -
Net Income Cont. Operations 2,457
Non Recurring Events

Discontinued Operations -
Extraordinary Items -
Effect of Accounting Changes -
Other Items -
Net Income 2,457
Preferred Stock and Other Adjustments -
Net Income Applicable to Common Shareholders 2,457

Recent News

Aug 6, 2014 Kelso Technologies Inc.: Financial Results for the Six Months Ended June 30, 2014
Jul 29, 2014 PHMSA/AAR/FRA-New Requirements for Rail Tank Cars
Jul 23, 2014 Transport Canada-New Requirements for TC/DOT 111 Tank Cars
Jul 7, 2014 Kelso Technologies Inc.: Grant of Option



KEOSF Kelso Technologies, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=KEOSF&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/KEOSF/quote
Stock Chart http://www.otcmarkets.com/stock/KEOSF/chart
Company Info http://www.otcmarkets.com/stock/KEOSF/company-info
Recent News http://www.otcmarkets.com/stock/KEOSF/news
Financials http://www.otcmarkets.com/stock/KEOSF/financials
Filings and Disclosure http://www.otcmarkets.com/stock/KEOSF/filings
Short Sales http://www.otcmarkets.com/stock/KEOSF/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/KEOSF/insider-transactions
Research Reports http://www.otcmarkets.com/stock/KEOSF/research
Summary http://finance.yahoo.com/q?s=KEOSF
Historical Prices http://finance.yahoo.com/q/hp?s=KEOSF+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=KEOSF
Basic Chart http://finance.yahoo.com/q/bc?s=KEOSF+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=KEOSF+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=KEOSF+Headlines
Press Releases http://finance.yahoo.com/q/p?s=KEOSF+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=KEOSF+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=KEOSF+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=KEOSF+Industry
Major Holders http://finance.yahoo.com/q/mh?s=KEOSF+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=KEOSF+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=KEOSF+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=KEOSF
Balance Sheet http://finance.yahoo.com/q/bs?s=KEOSF
Cash Flow http://finance.yahoo.com/q/cf?s=KEOSF+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/KEOSF
Market Watch http://www.marketwatch.com/investing/stock/KEOSF
Bloomberg http://www.bloomberg.com/quote/KEOSF:US
Morningstar http://quotes.morningstar.com/stock/s?t=KEOSF
Bussinessweek http://investing.businessweek.com/research/st...cker=KEOSF
Barchart http://www.barchart.com/quotes/stocks/KEOSF
OTC Short Report http://otcshortreport.com/index.php?index=KEOSF
Investopedia http://www.investopedia.com/markets/stocks/KEOSF/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 29

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 23

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 17

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 16

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 22

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 23

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Showcases Innovation at Healthcare Event

Updated Category News Views 142

Alterity Therapeutics to Present at a Virtual Healthcare Conference Alterity Therapeutics, a biotechnology firm dedicated to developing treatments for neurodegenerative diseases, has recently announced its participation in an upcoming healthcare virtual conference. The event will shine a spotlight on influential healthcare companies and their innovative approaches to...

Continue Reading
Important Update for Toronto-Dominion Bank Investors on Lawsuit

Updated Category News Views 58

Update for Investors in Toronto-Dominion Bank Kahn Swick & Foti, LLC, led by the experienced former Louisiana Attorney General Charles C. Foti, Jr., is reminding investors that significant changes are arriving for shareholders of Toronto-Dominion Bank (NYSE: TD). As the legal landscape evolves, those who experienced losses may want to take immediate action regarding their...

Continue Reading
GCC's Quarterly Performance Analysis: Key Insights Revealed

Updated Category News Views 221

GCC Reports Significant First Quarter Financials GCC, S.A.B. de C.V. (BMV: GCC*), recognized as a premier supplier and producer of cement, concrete, and aggregates, has shared its financial results for the first quarter. Despite facing various challenges, GCC's performance metrics reveal a resilience that is noteworthy. Q1 2025 Highlights In the first quarter of 2025, GCC...

Continue Reading
Indonesia's IDX Composite Index Declines Amid Market Pressures

Updated Category News Views 116

Overview of Recent Market Movements in Indonesia Indonesia's stock market experienced a downturn at the close of trading, influenced by various sectors showing significant losses. The IDX Composite Index reflected a decrease of 0.98%, marking a notable dip to a one-month low. This downturn is primarily attributed to declines in several key sectors, including...

Continue Reading
Blink Charging Achieves Advanced Certification for EV Chargers

Updated Category News Views 130

Blink Charging Receives Prestigious OCPP 2.0.1 Certification Blink stands out as one of just five EV charging companies in the U.S. to earn this coveted certification. Bowie, Md. – Blink Charging Co. (NASDAQ: BLNK), a prominent name in electric vehicle (EV) charging equipment and services, has proudly announced that its Series 7, 8, and 9 charger models have...

Continue Reading